Pharma & Biotech Citi starts Hikma at 'buy' with strategy reset offering compelling entry point By Ian Lyall 16/07
Financial Services Power Metallic well-positioned for second-half catalysts, Noble Capital Markets says By Proactive 16/07
Oil & Gas Reconnaissance Energy Africa reports initial hydrocarbon production at Kavango West 1X By Proactive 16/07
Pharma & Biotech CelLBxHealth builds £3.5m weighted pipeline as revenue growth target held By Ian Lyall 15/07
Mining Power Metallic reports final Lion Zone drill assays at Quebec's Nisk project ahead of resource estimate By Proactive 15/07
Software & services Nextech3D.ai launches enterprise pilot for AI workforce platform KraftyLab Intelligence By Proactive 15/07
Energy D3 Energy establishes maiden helium and hydrogen resource at South Australia’s PEL121 By Proactive 15/07
Pharma & Biotech Poolbeg Pharma raises £3.5m to support key trial and GLP-1 progress By Ian Lyall 14/07
Chemicals Itaconix lands first supply deal for its plastic-free dishwasher tablets By Jamie Ashcroft 14/07
Uranium Standard Uranium reports anomalous uranium results from inaugural Corvo drill program By Proactive 14/07
Pharma & Biotech Cavendish sees multi-billion-dollar prize as Poolbeg begins pivotal trial By Ian Lyall 13/07
Pharma & Biotech Genflow Biosciences dog trial continues to show longevity improvements By Jamie Ashcroft 13/07
Mining First Phosphate closes final tranche of private placement, raises total of C$17.7M By Proactive 13/07
